Literature DB >> 16778305

Glycobiology of Leishmania donovani.

Sumi Mukhopadhyay1, Chitra Mandal.   

Abstract

Leishmania donovani, the causative organism of visceral leishmaniasis (VL) is one of the deadliest of the entire known Leishmania species. This protozoan parasite displays immense adaptability to survive under extremely harsh conditions. Cell surface glycoconjugates play a pivotal role in parasite virulence and infectivity. This review mainly highlights on the importance of these molecules and their reported roles with special emphasis on L. donovani sialobiology. The recently evolved information reported by our group regarding the identification and characterization of sialoglycans and their possible mode(s) of acquisition as also the detailed identification, characterization of anti-O-acetylated sialic acid (anti-OAcSA) antibodies and their emerging biological roles, notably as molecules that may aid in host defense against the pathogen has been vividly discussed in this review.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16778305

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  12 in total

1.  High levels of serum glycans monovalent IgG immune complexes detected by dissociative ELISA in experimental visceral leishmaniasis.

Authors:  Camila Aparecida de Carvalho; Thiago Fidelis Ferrão; Flávia Regina Novais de Freitas; Heitor Franco de Andrade
Journal:  Immunology       Date:  2019-10-01       Impact factor: 7.397

2.  Evidence for rosettes as an unrecognized stage in the life cycle of Leishmania parasites.

Authors:  David M Iovannisci; C Paul Plested; Gregory R Moe
Journal:  J Eukaryot Microbiol       Date:  2010-08-05       Impact factor: 3.346

3.  Detection and characterization of a sialoglycosylated bacterial ABC-type phosphate transporter protein from patients with visceral leishmaniasis.

Authors:  Angana Ghoshal; Sumi Mukhopadhyay; Rodion Demine; Michael Forgber; Saulius Jarmalavicius; Bibhuti Saha; Shyam Sundar; Peter Walden; Chhabinath Mandal; Chitra Mandal
Journal:  Glycoconj J       Date:  2009-01-29       Impact factor: 2.916

4.  The major surface protease (MSP or GP63) in the intracellular amastigote stage of Leishmania chagasi.

Authors:  Chia-Hung Christine Hsiao; Chaoqun Yao; Patricia Storlie; John E Donelson; Mary E Wilson
Journal:  Mol Biochem Parasitol       Date:  2007-10-30       Impact factor: 1.759

Review 5.  The Role of Sialic Acids in the Establishment of Infections by Pathogens, With Special Focus on Leishmania.

Authors:  Tainá Cavalcante; Mariana Medina Medeiros; Simon Ngao Mule; Giuseppe Palmisano; Beatriz Simonsen Stolf
Journal:  Front Cell Infect Microbiol       Date:  2021-05-13       Impact factor: 5.293

6.  A perspective on the emergence of sialic acids as potent determinants affecting leishmania biology.

Authors:  Angana Ghoshal; Chitra Mandal
Journal:  Mol Biol Int       Date:  2011-07-25

7.  Glycosylation of erythrocyte spectrin and its modification in visceral leishmaniasis.

Authors:  Sajal Samanta; Devawati Dutta; Angana Ghoshal; Sumi Mukhopadhyay; Bibhuti Saha; Shyam Sundar; Saulius Jarmalavicius; Michael Forgber; Chhabinath Mandal; Peter Walden; Chitra Mandal
Journal:  PLoS One       Date:  2011-12-02       Impact factor: 3.240

8.  Glycoproteins in circulating immune complexes are biomarkers of patients with Indian PKDL: A study from endemic districts of West Bengal, India.

Authors:  Priyank Jaiswal; Souvik Datta; Bikash Sardar; Surya Jyoti Chaudhuri; Dipankar Maji; Manab Ghosh; Bibhuti Saha; Sumi Mukhopadhyay
Journal:  PLoS One       Date:  2018-02-08       Impact factor: 3.240

Review 9.  Sialic acids siglec interaction: a unique strategy to circumvent innate immune response by pathogens.

Authors:  Biswajit Khatua; Saptarshi Roy; Chitra Mandal
Journal:  Indian J Med Res       Date:  2013-11       Impact factor: 2.375

10.  Leishmania donovani Utilize Sialic Acids for Binding and Phagocytosis in the Macrophages through Selective Utilization of Siglecs and Impair the Innate Immune Arm.

Authors:  Saptarshi Roy; Chitra Mandal
Journal:  PLoS Negl Trop Dis       Date:  2016-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.